Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein

Benjamin Koch1, Patricia Schult-Dietrich2, Stefan Büttner1

  • 1Goethe University Hospital, Med. III, Division of Nephrology, Dialysis and Transplantation, Frankfurt, Germany.

Blood Purification
|April 27, 2018
PubMed
Abstract

Insights

Lectin affinity plasmapheresis (LAP) effectively removed Middle East respiratory syndrome coronavirus (MERS-CoV) and Marburg virus (MARV) glycoproteins in vitro. This suggests LAP could be a potential treatment for these emerging zoonotic pathogens.

Area of Science:

  • Virology
  • Infectious Diseases
  • Medical Technology

Background:

  • Middle East respiratory syndrome coronavirus (MERS-CoV) and Marburg virus (MARV) are WHO-identified emerging pathogens.
  • Both zoonotic diseases present with non-specific symptoms, high mortality, and limited treatment options.
  • Extracorporeal virus and glycoprotein elimination via lectin affinity plasmapheresis (LAP) was investigated.

Purpose of the Study:

  • To evaluate the efficacy of LAP in removing MERS-CoV and MARV components in vitro.
  • To assess the time-dependent clearance and binding resin saturation of LAP devices.

Main Methods:

  • LAP devices (Mini Hemopurifiers) were tested using MERS-CoV pseudovirus and MARV glycoproteins (GPs).
  • Negative controls were used for comparison.
  • Samples were analyzed every 30 minutes for virus infectivity (MERS-CoV) and soluble GP content (MARV).

Main Results:

  • LAP demonstrated time-dependent clearance of MERS-CoV pseudovirus (up to 80% in 3 hours).
  • Up to 70% of MARV soluble GPs were eliminated within the same timeframe.
  • Significant saturation of LAP binding resins occurred within the first hour of treatment.

Conclusions:

  • LAP effectively eliminates MERS-CoV pseudovirus and MARV soluble GPs in vitro.
  • Given the high fatality rates and lack of treatments, in vivo evaluation of LAP is warranted.
  • Early initiation, continuous therapy, and timely cartridge exchange may be crucial for LAP efficacy.

Related Concept Videos

Affinity and Avidity01:41

Affinity and Avidity

Overview
39.2K
Electron Affinity03:07

Electron Affinity

The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.6K
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.2K
What are Viruses?00:50

What are Viruses?

Overview
128.4K
Anatomy of Respiratory System II: Lower Respiratory Tract01:31

Anatomy of Respiratory System II: Lower Respiratory Tract

The lower respiratory tract is anatomically composed of several vital structures, including the larynx, trachea, bronchial tree, alveoli, lungs, and pleurae. Each component has a specific function, and all are intricately connected to ensure efficient respiration.
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
3.9K
The Respiratory System01:16

The Respiratory System

The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
89.7K